Events After the End of the Reporting Period

Financing activities

On July 10, 2026, Bayer signed an agreement with Apollo Global Management, Inc., United States, to secure a capital contribution of €3.0 billion. Under the agreement, the global asset management firm will obtain a minority, noncontrolling stake in a newly established entity holding Bayer’s long-acting reversible contraceptives (LARC) business, while Bayer will retain a majority stake and continue to exercise complete operational control. The transaction is expected to close in the second half of 2026, subject to approval by antitrust authorities and customary closing conditions.

In July 2026, Bayer US Finance LLC, St. Louis, United States, placed bonds with a volume of US$ 5.0 billion (€4.4 billion) that are guaranteed by Bayer AG. The placement comprises five tranches with maturities of between 5 and 30 years and fixed interest rates of between 5.125% and 6.375% p.a.

Also in July 2026, Bayer AG issued two additional bonds on the Chinese capital market. Known as “Panda” bonds, the issuances have a volume of CNY 3.0 billion (€386 million) and CNY 1.0 billion (€129 million), as well as maturities of three and five years and coupons of 1.9% and 2.2%, respectively.

Furthermore, in July 2026, Bayer AG and Bayer Corporation, United States, repaid commercial paper with a nominal volume of €170 million and US$ 381 million (€333 million), respectively.

Leverkusen, July 30, 2026
Bayer Aktiengesellschaft

The Board of Management